GHIF portfolio company Atomo Diagnostics lists on Australian Securities Exchange
The Global Health Investment Fund’s (GHIF) portfolio company Atomo Diagnostics Limited (AT1) has commenced trading on the Australian Securities Exchange (ASX) following an oversubscribed initial public offering (IPO). The Australian rapid blood test company intends to use the net proceeds from the IPO to support the planned expansion of its production